Figures
Abstract
Purpose
Multipotent stromal cell (MSC)-based regenerative strategy has shown promise for the repair of cartilage, an avascular tissue in which cells experience hypoxia. Hypoxia is known to promote the early chondrogenic differentiation of MSC. The aim of our study was therefore to determine whether low oxygen tension could be used to enhance the regenerative potential of MSC for cartilage repair.
Methods
MSC from rabbit or human adipose stromal cells (ASC) were preconditioned in vitro in control or chondrogenic (ITS and TGF-β) medium and in 21 or 5% O2. Chondrogenic commitment was monitored by measuring COL2A1 and ACAN expression (real-time PCR). Preconditioned rabbit and human ASC were then incorporated into an Si-HPMC hydrogel and injected (i) into rabbit articular cartilage defects for 18 weeks or (ii) subcutaneously into nude mice for five weeks. The newly formed tissue was qualitatively and quantitatively evaluated by cartilage-specific immunohistological staining and scoring. The phenotype of ASC cultured in a monolayer or within Si-HPMC in control or chondrogenic medium and in 21 or 5% O2 was finally evaluated using real-time PCR.
Results/Conclusions
5% O2 increased the in vitro expression of chondrogenic markers in ASC cultured in induction medium. Cells implanted within Si-HPMC hydrogel and preconditioned in chondrogenic medium formed a cartilaginous tissue, regardless of the level of oxygen. In addition, the 3D in vitro culture of ASC within Si-HPMC hydrogel was found to reinforce the pro-chondrogenic effects of the induction medium and 5% O2. These data together indicate that although 5% O2 enhances the in vitro chondrogenic differentiation of ASC, it does not enhance their in vivo chondrogenesis. These results also highlight the in vivo chondrogenic potential of ASC and their potential value in cartilage repair.
Citation: Portron S, Merceron C, Gauthier O, Lesoeur J, Sourice S, Masson M, et al. (2013) Effects of In Vitro Low Oxygen Tension Preconditioning of Adipose Stromal Cells on Their In Vivo Chondrogenic Potential: Application in Cartilage Tissue Repair. PLoS ONE 8(4): e62368. https://doi.org/10.1371/journal.pone.0062368
Editor: Abhay Pandit, National University of Ireland, Galway, Ireland
Received: October 22, 2012; Accepted: March 20, 2013; Published: April 30, 2013
Copyright: © 2013 Portron et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was financed by grants from the "Courtin Arthritis Foundation ", the "Société Française de Rhumatologie", ANR, the young researchers "Scartifold" project, the ANR Tecsan "Chondrograft" project, the "Fondation de l'Avenir pour la Recherche Médicale Appliquée" FRM "Veillissement Osteoarticulaire" (ET7-451 and ET9-491), les Haras Nationaux, Graftys S.A. and the INSERM U791. CM and SP received a fellowship from the "Région des Pays de la Loire, Bioregos I and II program. Those funding had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: Jérôme Guicheux is a PLOS ONE Editorial Board member and the authors received funding from Graftys S.A.. However, this does not alter the authors' adherence to all PLOS ONE policies on the sharing of data and materials.
Introduction
Articular cartilage is an avascular and poorly cellularized tissue that has a limited capacity for self-repair after injury. Indeed, only full-thickness defects, which affect both the subchondral bone and cartilage exhibit a repair process that leads to the formation of fibrocartilage. This fibrocartilage does not however display the mechanical properties of native articular cartilage [1] and unfortunately degrades rapidly. This degradation may progress into a premature wear of cartilage and often leads to degenerative joint disease. Different surgical strategies are currently considered such as microfracture [2] or mosaicplasty [3]. For the treatment of cartilage defects, none of these techniques results in a complete regeneration of cartilage tissue [4]. To address this clinical issue, autologous chondrocyte transplantation (ACT) initially developed by Brittberg et al. has been introduced into clinical use to treat focal lesions of the knee joint [5], [6], [7]. Given the limitations of autologous chondrocytes (lack of availability and dedifferentiation during amplification), the use of multipotent stromal cells (MSC) for cartilage tissue engineering has recently attracted growing interest [8], [9], [10]. Among the various tissues from which MSC can be isolated, bone marrow has been the most widely used in cartilage repair strategies [11], [12], [13]. However, adherent cells isolated from stromal vascular fraction of adipose tissue also exhibit the major characteristics of stemness (proliferation, long-term self-renewal, and multilineage differentiation) [14] and were named adipose stromal cells (ASC) accordingly [15].
Interestingly, adipose tissue stromal vascular fraction contains 10- to 100-fold more clonogenic cells than bone marrow [16], [17], [18] and is easily accessible through non-invasive liposuction. These practical advantages make ASC an attractive cell population for use in cartilage repair.
Cartilage repair strategies combining MSC and biomaterials have been thoroughly explored recently [10], [19], [20], [21], [22]. In addition to providing a vehicle for the delivery of cells, biomaterials supply a three-dimensional environment suitable for the chondrogenesis of MSC [23], [24].
The use of in vitro differentiated MSC for biomaterial-assisted cartilage repair, as opposed to undifferentiated MSC, results in faster and improved tissue repair [25], [26]. However, despite recent progress in understanding MSC biology, the chondrogenic differentiation of MSC remains difficult to control. For this reason, research teams have focused on developing effective culture methods to optimize the chondrogenesis of MSC. While the use of growth factors (such as TGF, BMPs and IGF) for the chondrogenic differentiation of MSC has been widely explored [27], [28], the use of environmental factors, such as oxygen tension, has only recently been contemplated [29].
As mentioned above, cartilage is an avascular tissue in which chondrocytes experience low oxygen tension [30], [31], [32], ranging from 2 to 7% O2. Several studies report converging data indicating that low oxygen tension could enhance the chondrogenic differentiation of bone marrow-derived MSC in the presence of induction medium [33], [34]. Of particular interest is Merceron et al.'s finding that 5% O2 promotes the chondrogenesis of ASC [35]. These data together suggest that low oxygen tension contributes to controlling the chondrogenic commitment and differentiation of various types of progenitor cells including ASC. However, despite a large body of evidence on the in vitro prochondrogenic effects of low oxygen tension, it remains unknown whether chondrogenic commitment under low oxygen tension may affect the formation of cartilaginous tissue in vivo.
Therefore, the aim of the present study was to determine whether low oxygen tension could be used to enhance the regenerative potential of MSC for cartilage repair. For this purpose, we first assessed the impact of in vitro preconditioning with low oxygen tension of ASC on their in vivo chondrogenic potential. Next, we investigated two complementary models: (i) the repair of rabbit cartilage defects by the transplantation of autologous ASC in a cellulose-based hydrogel (Si-HPMC hydrogel) and (ii) the formation of cartilaginous tissue by subcutaneous transplantation of human ASC in Si-HPMC hydrogel in nude mice.
Materials and Methods
Materials
Hydroxypropyl methylcellulose (HPMC) E4M was purchased from Colorcon-Dow chemical (Bougival, France). Glycidoxypropyltrimethoxysilane (3-GPTMS) was obtained from Acros (Geel, Belgium). Cell culture plastic wares were purchased from Corning BV (Schipol-Rijk, The Netherlands). Hank's Balanced Salt Solution (HBSS), Dulbecco's Modified Eagle's Medium–High Glucose (4.5 g/L) (DMEM), Phosphate-Buffered Saline (PBS), penicillin/streptomycin, trypsin-EDTA (0.05%/0.53 mM), Trizol®, L-glutamine and Superscript® III kit were obtained from Invitrogen (Paisley, UK). 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), type IA crude collagenase, red blood cell lysis buffer, sodium L-ascorbate, Insulin Transferrin Sodium Selenite (ITS) media supplement, dexamethasone, alcian blue, hyaluronidase and type II collagenase (290 units/mg) were purchased from Sigma-Aldrich (St. Louis, MO). TGF-β1 was obtained from PeproTech Inc. (London, UK). NucleoSpin® RNA II was obtained from Macherey-Nagel (Hoerdt, France). Brilliant® SYBR® Green Master Mix was obtained from Stratagene (La Jolla, CA). The PCR primers were synthesized by MWG Biotech (Ebersberg, Germany). Fetal calf serum (FCS) was purchased from Dominique Dutscher (Brumath, France). Technovit 9100 New® was obtained from Heraeus Kulzer (Wehrheim/Ts, Germany). The mouse monoclonal antibody directed against human and rabbit type II collagen was purchased from MP Biomedicals (Solon, OH). The biotinylated goat anti-mouse IgG antibody, the Universal Dako LSAB® (labelled streptavidin biotin reagents) and peroxidase kit were purchased from Dako (Trappes, France). All other chemicals were obtained from standard laboratory suppliers and were of the highest grade of purity available.
Preparation of Si-HPMC hydrogel
As previously described, Si-HPMC (silanized hydroxypropyl methylcellulose) was synthesized by grafting 14.24% 3-GPTMS onto E4M1 in heterogeneous medium [36]. Si-HPMC powder (3% w/v) was solubilized in 0.2 M NaOH under constant stirring for 48 h. The solution was then sterilized by steam (at 121°C for 20 min). Finally, to allow the formation of a reticulated hydrogel, the solution was mixed with 0.5 volume of 0.26 M HEPES buffer. The final product was a viscous liquid at pH 7.4, which allowed cell incorporation. The cell/Si-HPMC hydrogel mixture was then reticulated for approximately 30 min, as previously described [36].
Rabbit and mice surgery
Rabbit and mouse handling, as well as surgical procedures, were conducted according to European Community guidelines for the care, accommodation and use of laboratory animals (DE 86/609/CEE; modified DE 2003/65/CE). Experiments were performed according to good laboratory practices at the Center for Preclinical Research and Investigation of the ONIRIS Nantes-Atlantic College of Veterinary Medicine, Food Science and Engineering. All rabbit experimental studies were performed on adult female New Zealand White rabbits weighing 3 to 3.5 kg (Charles River, L′Arbresle, France). All mouse experimental studies were performed on 1-month-old female Swiss nude mice (Charles River, L′Arbresle, France). General anesthesia of rabbits was induced by intramuscular injection of ketamine (0.5 mL/kg, Imalgene 1000®, Merial SAS, France) and xylazine (0.3 mL/kg, Rompun®, Bayer, France) cocktail.
Intravenous injections were carried out to extend intramuscular administration until effects at one tenth of the initial intramuscular dosage and repeated on demand, once or twice during the whole surgical period.
Pre-operative analgesia was provided through subcutaneous injection of morphine chlorhydrate (2 mg/kg). Immediate post-operative analgesia was provided through subcutaneous injection of meloxicam (0.1 mg/kg, Metacam®, Boehringer Ingelheim, France), and prolonged for 5 days orally. Rabbits were euthanized by intra-cardiac injection of 5 mL of pentobarbital (Dolethal®, Vetoquinol S.A., France) after inducing general anesthesia as described above.
Mice were pre-medicated with morphine chlorhydrate (2 mg/kg) diluted into sterile saline solution and injected subcutaneously. General anesthesia was obtained in an induction chamber with isoflurane (2%) delivered in O2 and prolonged through an individual mask. Mice were euthanized by an overdose of isoflurane within an induction chamber.
Isolation, expansion and chondrogenic differentiation of rabbit and human adipose stromal cells
ASC were obtained from human patients (hASC) undergoing liposuction and who had given written consent (ethics committees: Agence de BioMedecine, n°PFS08-018, the legislation code L.1211-3 toL.1211-9: residues obtained during a surgical procedure, performed in the interest of the person operated, can be used for scientific research), or from autologous rabbit adipose tissue (rASC) harvested from the inguinal region. Briefly, and as previously described [35], human lipoaspirate and rabbit adipose tissue were shredded into small pieces and washed extensively with HBSS. The washed adipose tissue was treated with collagenase (0.025%) in HBSS for 1 h at 37°C under gentle agitation. The collagenase was inactivated by adding an equal volume of DMEM containing 1% penicillin/streptomycin, 1% L-glutamine and 10% FCS (control medium). The digested product was then centrifuged at 250 g for 5 min to separate adipose fraction from stromal fraction. The supernatant was removed and the stromal cells were re-suspended in the control medium and filtered through a 70 µm nylon mesh filter. The filtrate was centrifuged and the cells were re-suspended in red blood cell lysis buffer. The lysis reaction was stopped by adding control medium. The suspension was centrifuged and the cells were finally re-suspended in control medium and plated at a density of 5×104 cells/cm2.
hASC isolated using the protocol described above have been extensively characterized in our laboratory (for details see [35], [37]).
The medium was replaced 24 h after seeding to remove non-adherent cells. To prevent spontaneous differentiation, primary cultures (P0) of ASC were grown to approximately 80% of confluence and then detached from the cell culture flask using trypsin-EDTA. For all subsequent experiments, ASC at passage 2 were used.
All culture incubations were performed at 37°C in a humidified atmosphere containing 5% CO2 and the medium was changed every 2 to 3 days.
For in vitro chondrogenic differentiation, ASC were divided into three experimental groups. The cells were cultured for 21 days in monolayers (1×104 cells/cm2) under normoxic conditions (21% O2) in control medium (NCT) or in chondrogenic medium (NCH); otherwise, they were cultured under hypoxic conditions (5% O2) in chondrogenic medium (HCH). The chondrogenic medium was composed of serum-free DMEM supplemented with 1% penicillin/streptomycin, 6.25 µg/mL insulin, 6.25 µg/mL transferrin, 6.25 ng/mL sodium selenite (ITS), 50 nM sodium L-ascorbate, 1×10−8 M dexamethasone and 10 ng/mL TGF-β1 as described previously [35], [38]. For in vitro culture under hypoxic conditions, ASC were incubated at 37°C, in a tri-gas incubator (Binder, Tuttlingen, Germany) delivering 5% CO2, 5% O2 and 90% N2 in a humidified atmosphere.
3D culture of human adipose stromal cells in Si-HPMC hydrogel
As described previously, hASC were collected and gently mixed with Si-HPMC hydrogel at a density of 2×106 cells/mL of hydrogel [39]. The hASC/Si-HPMC mixture was distributed in 12-well plates (1 mL/well) and incubated at 37°C and 5% CO2. After a 2 h-incubation, control medium was added. After 24 h, hASC/Si-HPMC hydrogel constructs were separated into three experimental groups and cultured in NCT, NCH and HCH conditions for 21 days. The media were changed every 2 to 3 days.
Real-time PCR analysis of the chondrogenic differentiation of rabbit and human adipose stromal cells
Total RNA was extracted from monolayer cultures using a Nucleospin® ARN II kit in accordance with the manufacturer's instructions. For hASC cultured in the 3D Si-HPMC hydrogel, total RNA was extracted with Trizol®. One microgram of total RNA was reverse-transcribed using the Superscript® III kit in a total volume of 20 µL. Complementary DNA (cDNA) was amplified in a total volume of 25 µL of PCR reaction mix containing 12.5 µL of Brilliant® SYBR® Green Master Mix (1X), 30 nM SYBR green reference dye and each primer at a concentration of 10 µM. The sequences of the rabbit and human primers are provided in Tables 1 and 2, respectively. The COL2A1 gene encodes the alpha-1 chain of type II collagen, a fibrillar collagen found specifically in cartilage. The ACAN gene encodes aggrecan core protein. Aggrecan is the major member of the proteoglycan family found in the extracellular matrix of cartilaginous tissue. Real-time PCR was performed in a MX3000P® real-time PCR system (Stratagene) under the following conditions: 10 min at 95°C followed by 40 cycles of 30 s at 95°C, 1 min at 60°C and 30 s at 72°C. The efficiency and specificity of each primer set was confirmed using standard curves of cycle threshold values vs. serial dilutions of total RNA and by evaluating the melting profile. Cycle thresholds were normalized to those of β-actin, used as the reference gene, to control for differences in cDNA quantification. The results were reported as relative expression levels.
Implantation of rabbit adipose stromal cells within Si-HPMC hydrogel in rabbit articular defects
After a medial parapatellar incision, the patella was luxated laterally. Two osteochondral defects with a diameter of 3 mm and a depth of 4 mm were created in the patellar groove of the femur, using a surgical round bur on a slow-speed rotary dental handpiece, as described previously [10]. The surgical procedure was performed on both sides. For the implantation of autologous rASC/Si-HPMC hydrogel into articular cartilage defects, cells were individualized by tryspin/EDTA treatment, centrifuged at 250 g for 5 min. Two million individualized rASC were gently mixed with 200 µL of the Si-HPMC hydrogel before its reticulation. Defect sites were filled with the Si-HPMC hydrogel containing autologous rASC preconditioned in NCT, NCH, or HCH conditions. As reported previously [10], autologous rabbit nasal chondrocytes (RNCs), used as the positive control, were implanted at a density of 0.5×106 RNC/200 µL of Si-HPMC hydrogel. Autologous RNCs were isolated from the nasal septum, harvested and cultured, as described previously [10]. The four different conditions (rASC cultured in NCT, NCH, HCH and RNC) were tested in triplicates and three animals received implants (four implants per rabbit; two per patellar groove). After surgery, the animals were allowed to move freely in their cages. After eighteen weeks, rabbits were sacrificed and the samples were histologically processed as described below.
Implantation of human adipose stromal cells within Si-HPMC hydrogel in nude mice subcutis
hASC were cultured in NCT, NCH and HCH for three weeks and 0.5×106cells were individualized and gently mixed with 250 µL of Si-HPMC hydrogel prior to subcutaneous implantation into nude mice, as described previously [37]. As a control, primary horse nasal chondrocytes (HoNCs) incorporated into Si-HPMC hydrogel (0.5×106 HoNC/250 µL) were injected subcutaneously.
The four different conditions (ASC cultured in NCT, NCH, HCH and HoNCs) were tested in triplicates and six animals received implants (two implants per animal). The animals were sacrificed five weeks after implantation and the samples were processed histologically as described below.
Histological analysis of explants
A group of rabbit explants was embedded in resin Technovit 9100 New® as described by Yang et al. [40] and stained using Movat's pentachrome [41].
The second group of rabbit explants, mice explants and hASC cultured in the Si-HPMC hydrogel were embedded in paraffin and stained or immunostained, as described previously [37], [42]. Briefly, the explants embedded in resin and paraffin were cut in 5 µm-thick sections passing through the middle of the defects in the coronal plane. The production of a cartilaginous matrix containing sulfated glycosaminoglycans (GAG) and type II collagen was evaluated using alcian blue staining and type II collagen immunostaining, respectively. For type II collagen immunostaining, human nasal cartilage sections were used as a positive control. As a negative control, the sections were processed using an identical protocol, but omitting the primary antibody. The sections were then visualized using a light microscope (Zeiss Axioplan2, Göttingen, Germany), with immuno-positive areas exhibiting brown staining.
The histological sections were evaluated by double-blind, randomized scoring performed by five trained, independent examiners for each section (n = 3 per replicate). To evaluate the quality of the repaired tissue in rabbits after surgery, the sections were scored according to O′Driscoll's method [43]. O′Driscoll scoring assesses the nature of the predominant tissue (cellular morphology 0–4; matrix staining 0–3), the structural characteristics (surface regularity 0–3; surface integrity 0–2; thickness 0–2; bonding to the adjacent cartilage 0–2), cellular degenerative changes (hypocellularity 0–3; chondrocyte clustering 0–2) and changes in adjacent cartilage (0–3). The score for a normal cartilage is 24.
Statistical analysis
Each in vitro experiment was repeated at least three times with similar results. Results are expressed as mean ± SEM of triplicate determinations. Means were compared using a one-way ANOVA followed by a post-hoc test (Tukey's honestly significant difference). Histological grading scores were analyzed using the Wilcoxon Mann-Whitney test. A p-value <0.05 was considered statistically significant.
Results
Chondrogenic potential of differentially preconditioned rabbit adipose stromal cells
Prior to investigating the in vivo effects of hypoxic preconditioning of autologous rASC, we characterized the in vitro phenotype of differentially preconditioned rASC. The rASC were cultured in a monolayer under NCT, NCH, or HCH conditions (Fig. 1A). Our real-time PCR data indicate that, in the NCT condition, the expression of type II collagen (col2a1) mRNA could not be detected (ND) and aggrecan (acan) mRNA was barely detectable. The expression of col2a1 and acan became detectable in the NCH condition and substantially increased in rASC cultured in HCH conditions with significant 4.5- and 1.6-fold increases, respectively, compared with the NCH condition (Fig. 2A).
A) Schematic overview of the chondrogenic potential of differentially preconditioned rabbit adipose stromal cells (rASC). rASC were isolated and cultured under normoxic conditions (21% O2) in control medium or chondrogenic medium or under hypoxic conditions (5% O2) in chondrogenic medium. As a positive control, rabbit nasal chondrocytes (RNC) were used. Preconditioned rASC and RNC were finally associated with Si-HPMC hydrogel and implanted in rabbit articular cartilage defects for 18 weeks. B) Schematic overview of the chondrogenic potential of differentially preconditioned human adipose stromal cells (hASC). hASC were isolated and cultured under normoxic conditions (21% O2) in control medium or chondrogenic medium or under hypoxic conditions (5% O2) in chondrogenic medium. As a positive control, horse nasal chondrocytes (HoNC) were used. Preconditioned hASC and HoNC were finally associated with Si-HPMC hydrogel and implanted in nude mice subcutis for 5 weeks.
A) rASC were cultured under normoxic conditions (21% O2) in control medium (NCT) and chondrogenic medium (NCH) or under hypoxic conditions (5% O2) in chondrogenic medium (HCH). The expression of transcripts encoding type II collagen (col2a1) and aggrecan (acan) was measured by real-time PCR. The results are expressed as relative expression levels. ND: not detected. # p<0.05 compared with NCT; * p<0.05 compared with NCH. B) rASC were cultured in NCT (a, b, c, d), NCH (e, f, g, h), or HCH (i, j, k, l) and implanted with the Si-HPMC hydrogel in rabbit osteochondral defects. Rabbit nasal chondrocytes (RNCs) incorporated into the Si-HPMC hydrogel were used as a control (m, n, o, p). After 18 weeks of implantation, the defects were macroscopically observed [gross appearance (a, e, i, m)], histologically stained using Movat's pentachrome (b, f, j, n) and alcian blue (c, g, k, o) and immunostained for type II collagen (d, h, l, p). a, e, i, m: bar indicates 1 mm. b–d; f–h, j–l, n–p: bar indicates 100 µm. C) A semi-quantitative analysis of the regenerated tissue was performed using O′Driscoll's repair score as described in the “Materials and Methods” section. The results are expressed as a mean O′Driscoll score.
We next aimed to determine the effects of in vitro hypoxic preconditioning of rASC on their in vivo chondrogenic potential. rASC were cultured in the three conditions mentioned above and implanted within a Si-HPMC hydrogel in rabbit articular cartilage defects.
The newly formed tissue after implantation of the differentially preconditioned rASC/Si-HPMC hydrogel was first histologically characterized. Movat's pentachrome staining (Fig. 2B b, f, j) revealed yellow collagen fibers, especially in the superficial zone, in the NCT and NCH conditions. Round/oval cells and green/blue stained GAG seemed to be more predominant in the middle and deep zones. Alcian blue staining (Fig. 2B c, g, k) and immunostaining for type II collagen (Fig. 2B d, h, l) revealed the presence of sulfated GAG and type II collagen in the three conditions. In the NCT condition, GAG was weakly stained and immunostaining for type II collagen remained slight. When rASC were preconditioned in the NCH condition, alcian blue staining remained weak and type II collagen was mainly noted in the deep zone of the newly formed tissue. For rASC preconditioned in the HCH condition, GAG and type II collagen were homogenously detected.
As expected, the implantation of the autologous RNC/Si-HPMC hydrogel induced the formation of a well-organized tissue (Fig. 2B n) rich in GAG (Fig. 2B o) and type II collagen (Fig. 2B p).
To further analyze the newly formed tissue, a semi-quantitative assessment was performed (Fig. 2C) using O′Driscoll's score. No difference between NCT- and NCH-preconditioned rASC and RNC was noted (16.5±0.1; 17.9±0.1; and 18.6±0.065, respectively). The score for HCH-preconditioned rASC/Si-HPMC (21.5±0.01) was slightly, but not significantly, higher when compared with the other conditions.
The histological analyses revealed that the implantation of differentially preconditioned rASC/Si-HPMC hydrogel constructs led to the formation of a repair tissue containing GAG and type II collagen to a similar extent, regardless of the type of preconditioning used. Thus, although low oxygen tension exerts an in vitro pro-chondrogenic effect, the in vivo articular environment could overcome this effect.
Chondrogenic potential of differentially preconditioned human adipose stromal cells
To counteract this potential effect of the articular environment and with the long-term goal of developing a human therapy, we next tested the subcutaneous implantation of human ASC in nude mice (Fig. 1B).
Before investigating the impact of hypoxic preconditioning of hASC on their in vivo chondrogenic potential, the phenotypes of differentially preconditioned hASC were first characterized. Our real-time PCR data revealed that the expression levels of COL2A1 and ACAN mRNA could be detected only for cells cultured in NCH and HCH (Fig. 3A). The mRNA for these genes was significantly upregulated 2- and 1.3-fold in chondrogenic medium under hypoxic conditions compared with normoxic conditions, respectively. Similar to the rASC findings, these results confirm that an induction medium is required for the induction of type II collagen and aggrecan expression and that 5% O2 increases their expression.
A) hASC were cultured under normoxic conditions (21% O2) in control medium (NCT) and chondrogenic medium (NCH) or under hypoxic conditions (5% O2) in chondrogenic medium (HCH). The expression of transcripts encoding type II collagen (COL2A1) and aggrecan (ACAN) was measured using real-time PCR. The results are expressed as relative expression levels. ND: not detected * p<0.05 compared with NCH. B) hASC were cultured in NCT (a, b), NCH (c, d) or HCH (e, f) and implanted with the Si-HPMC hydrogel into subcutaneous pockets of nude mice. Horse nasal chondrocytes (HoNCs) incorporated into the Si-HPMC hydrogel were used as a control (g, h). After five weeks, the samples were harvested, histologically stained using alcian blue (a, c, e, g) and immunostained for type II collagen (b, d, f, h). Bar indicates 20 µm.
To address the effects of hypoxic preconditioning on the chondrogenic potential of hASC in vivo, differentially preconditioned hASC were incorporated into Si-HPMC hydrogel and injected into subcutaneous pockets of nude mice. The histological examination of the newly formed tissue using NCT-preconditioned hASC revealed the absence of cell aggregate formation (Fig. 3B a, b). In contrast, hASC implants that had been preconditioned in NCH or HCH revealed the formation of cell aggregates (Fig. 3B c, d, e, f) that were positively stained by alcian blue and immunoreactive for type II collagen, thus suggesting the production of a cartilaginous matrix. As expected, primary HoNCs used as the positive control revealed the formation of cartilage-like aggregates containing GAG and type II collagen (Fig. 3B g, h).
Although low oxygen tension exerts an in vitro prochondrogenic effect, our data reveal that hASC cultured in chondrogenic medium, regardless of oxygen tension, are able to form cartilaginous cell aggregates to a similar extent.
These findings suggest that Si-HPMC may be a suitable scaffolding hydrogel that allows cells to adequately sense their environment.
In vitro chondrogenic differentiation of 3D-cultured human adipose stromal cells
To address whether ASC cultured within the Si-HPMC hydrogel respond to a prochondrogenic environment (i.e., 3D culture, chondrogenic medium and low oxygen tension), hASC were cultured within Si-HPMC hydrogel in NCT, NCH and HCH conditions. The in vitro production of a cartilaginous matrix was evaluated by alcian blue staining and type II collagen immunostaining. hASC cultured in NCT/Si-HPMC hydrogel exhibited weak alcian blue staining and type II collagen immunostaining (Fig. 4A a, b). In contrast, hASC cultured in chondrogenic medium within the Si-HPMC hydrogel were positive for GAG and type II collagen, especially when cultured under 5% O2 (Fig. 4A c–f).
A) hASC were 3D cultured within the Si-HPMC hydrogel under normoxic conditions (21% O2) in control medium (NCT) (a, b) and chondrogenic medium (NCH) (c, d) or under hypoxic conditions (5% O2) in chondrogenic medium (HCH) (e, f). The presence of sulfated glycosaminoglycans and type II collagen was investigated using alcian blue staining (a, c and e) and type II collagen immunostaining (b, d and f), respectively. Bar indicates 20 µm. B) hASC were cultured in a monolayer or within the Si-HPMC hydrogel under normoxic conditions (21% O2) in control medium (NCT) and chondrogenic medium (NCH) or under hypoxic conditions (5% O2) in chondrogenic medium (HCH). The expression of transcripts encoding type II collagen (COL2A1) and aggrecan (ACAN) was measured by real-time PCR. The results are expressed as relative expression levels. # p<0.05 compared with NCT. * p<0.05 compared with NCH.
To further evaluate the scaffolding properties of the Si-HPMC hydrogel, we compared the expression of COL2A1 and ACAN mRNA in hASC cultured in monolayer or within the Si-HPMC hydrogel under the NCT, NCH and HCH conditions. According to the results obtained by real-time PCR, hASC cultured in a monolayer in NCT or in the NCT/Si-HPMC hydrogel barely expressed the two transcripts. In the monolayer condition, the chondrogenic medium induced a 2-fold increase in the expression of these transcripts, when compared with the NCT condition. In the Si-HPMC hydrogel condition, the chondrogenic medium induced 8- and 125-fold increases in the expression of COL2A1 and ACAN mRNA, respectively, when compared with the NCT condition (Fig. 4B).
In addition, a 3- and 6-fold increase in COL2A1 and ACAN transcripts, respectively, was observed in hASC cultured in the HCH monolayer, when compared with the NCH/monolayer. In Si-HPMC hydrogel, the expression of COL2A1 and ACAN was increased by 60- and 1.5-fold, respectively, for hASC cultured in HCH compared to those cultured in NCH.
These results suggest that hASC cultured within Si-HPMC hydrogel are responsive to a prochondrogenic medium and a 5% O2 tension. In addition, our data strongly suggest that a 3D culture within Si-HPMC hydrogel may support the capacity of the prochondrogenic condition to enhance the chondrogenic differentiation of hASC.
Discussion
In the last decade, MSC-based regenerative strategies have been thoroughly investigated for the formation of long-term functional tissue in cartilage repair. However, controlling the chondrogenic commitment and differentiation of MSC remains challenging [44]. Among the various chondrogenic factors that could be used to exploit the potential of MSC for cartilage regeneration, hypoxia is probably among the most tunable, safe and easy-to-use. In this context, we evaluated whether in vitro low oxygen tension could impact the cartilage regenerative potential of ASC after in vivo implantation.
Consistent with our previously published data [35], our in vitro results confirmed that low oxygen tension increased the expression of the two major chondrogenic markers in monolayer-cultured ASC of rabbit and human origin. This first set of experiments also allowed us to determine whether ASC exhibited different levels of chondrogenic commitment after in vitro preconditioning under various conditions (NCT, NCH and HCH), especially at the mRNA level.
Next, we evaluated the in vivo chondrogenic potential of these differentially preconditioned ASC. To enable the in vivo implantation of ASC, we used an injectable and self-setting cellulose-based hydrogel (Si-HPMC) that was developed for skeletal tissue engineering [42]. We then performed in vivo experiments in two complementary animal models that are widely used in cartilage tissue engineering: the repair of osteochondral defects in the rabbit knee joint [41] and the formation of subcutaneous cartilaginous cell aggregates in nude mice [37].
Based on our histological data and regardless of the preconditioning conditions, rabbit ASC were found to generate repair tissue in cartilage defects. It is well known, however, that the functional load-bearing capacity of cartilaginous repair tissue is dependent on the ultrastructural components and the organization of the newly formed tissue [45], [46]. On the one hand, vertical collagen fibers in the deep zone of the cartilage counteract swelling and protect the extracellular matrix from strain at the subchondral junction. On the other hand, horizontal fibers in the superficial zone play a critical role in tangential resistance to shear stress at the articular surface. Given the biomechanical relevance of this specific histological organization of hyaline cartilage, it was particularly notable in the present study that preconditioned ASC, especially in chondrogenic medium and hypoxic conditions, induced the formation of repair tissue that exhibited a hyaline-like organization. These data confirm the potential of ASC for cartilage engineering.
Surprisingly, although 5% oxygen tension dramatically stimulated the in vitro chondrogenic differentiation of rASC, it failed to significantly enhance the in vivo formation of cartilage-like tissue in the rabbit articular site.
However, a crucial point when interpreting the results from the in vivo cartilage repair experiments is determining how much the cells actually influenced the outcome, as spontaneous repair is known to occur in osteochondral defects [47].
Therefore, the repair of an osteochondral defect in rabbits would probably not constitute the most relevant model to accurately evaluate the regenerative potential of cells. Thus, to counteract the endogenous regenerative effects of the articular environment, we implanted human ASC in nude mice subcutis in one of the most widely established models used to decipher the regenerative potential of cell biomaterial constructs.
In this model, and in contrast to the effect observed for NCT-preconditioned cells, chondrogenically induced human ASC incorporated into Si-HPMC hydrogel formed cartilage-like cell aggregates enriched in type II collagen and GAG. However, as previously reported for rabbit knee joints, 5% low oxygen tension did not stimulate the formation of cartilage-like aggregates. In contrast to the data obtained using rabbit ASC in the cartilage defect model, the findings in the subcutaneous nude mouse model highlight the beneficial effect of the induction medium on the in vivo chondrogenesis of hASC. This discrepancy, regardless of differences between species, could arise from the cartilaginous articular environment, which may provide implanted cells with prochondrogenic stimuli, such as growth factors, low oxygen tension, and mechanical constraints [48]. These prochondrogenic stimuli are also known to favor MSC chondrogenesis and cartilage tissue maturation [49], [50]. In addition, the presence of progenitor cells in articular cartilage has been detected in the superficial zone of articular cartilage. Cell population CD105+/CD166+ exhibiting a high colony-forming efficiency, a chemotactic activity and limited multipotency has been described recently [51], [52], [53], [54]. These endogenous progenitors may influence the behavior of implanted cells and erase the differences observed after the preconditioning culture. However, the role and function of these endogenous progenitors have yet to be clearly deciphered, especially in the context of cartilage repair.
Altogether, the data obtained from the present rabbit and nude mice experiments demonstrate that although hypoxia strongly promotes the in vitro chondrogenic differentiation of ASC in a monolayer or entrapped within a Si-HPMC hydrogel, it fails to potentiate the formation of cartilaginous tissue in vivo. Viewing the discrepancy between the in vitro and in vivo data, it seems reasonable to speculate that cells implanted within Si-HPMC hydrogel experience some quite similar environmental factors, including low oxygen tension, that could greatly influence their ability to produce a cartilaginous tissue [30], [31]. The effects of this low oxygen tension are mainly to be mediated by the activation of the HIF transcription factor family [55]. As suggested by our in vitro data, such a low oxygen tension has indeed been reported to stimulate the chondrogenic differentiation through a specific stabilization of HIF1-alpha. It is well acknowledged that HIF-1 alpha/HIF-1 beta dimers upregulate the transcriptional activity of SOX9 promoter through binding on specific hypoxia-responsive element sequences [33], [56], which in turn increases the expression of type II collagen and aggrecan. In addition, it has been shown that low oxygen tension also contributes to the hydroxylation-mediated maturation of the collagen fibers through the increase in the expression of prolyl-4-hydroxylase [57], [58].
Regardless of the animal model used, one of the limitations in the present manuscript and in a large number of similar studies reported in the literature is the time point at which the formation of a repair tissue is investigated (18 weeks in rabbits and 5 weeks in nude mice). The maturation of the newly formed cartilage is indeed a complex, spatially- and temporally-regulated process that involved a large number of biological partners.
The Si-HPMC hydrogel that has long been considered a suitable vehicle for the delivery of cells in a cartilaginous defect via a minimally invasive surgical protocol should also be viewed as a permeable structure that allows cells to sense environmental prochondrogenic stimuli, such as growth factors, low oxygen tension and mechanical constraints.
Consequently, we hypothesized that the Si-HPMC hydrogel may provide a 3D scaffolding environment suitable for chondrogenesis. To address this issue, we cultured hASC in monolayers or within the Si-HPMC hydrogel under NCT, NCH and HCH conditions. Our results suggest that the in vitro 3D culture within the Si-HPMC hydrogel seems to enhance the prochondrogenic effects of the induction medium and hypoxia. Both these properties of our hydrogel are likely to make Si-HPMC a promising scaffolding biomaterial for MSC-based cartilage tissue engineering [10].
The successful regeneration of cartilage, however, requires that the cells be driven towards a stable articular phenotype, as opposed to a growth plate phenotype, which leads to hypertrophy and ultimately to cartilage calcification [59]. Five per cent oxygen has been shown to not only promote the chondrogenic differentiation of MSC, but also to prevent their hypertrophic differentiation [60], [61]. Thus, considering this effect of hypoxia on the terminal conversion of MSC towards a hypertrophic phenotype, testing whether hypoxic preconditioning of ASC could be used to prevent the formation of calcified tissue in vivo after long-term implantation remains of particular interest. This point will be addressed in future experiments.
Conclusions
Our study shows that concomitant treatment with low oxygen tension and a chondrogenic medium promotes the in vitro chondrogenic differentiation of ASC of rabbit and human origin. In addition, our data indicate that the in vitro chondrogenic differentiation of ASC, regardless of oxygen preconditioning, is required for optimal cartilage regeneration in vivo. Although hypoxic preconditioning of ASC did not improve in vivo regeneration in our models, whether such preconditioning may help prevent the formation of calcified cartilage in vivo remains to be determined. These data together provide new insights into the biology of MSC and could help take advantage of their regenerative potential for the development of a clinically relevant cartilage tissue repair procedure.
Acknowledgments
The authors also gratefully acknowledge Dr F. Lejeune (Clinique Bretéché Nantes) for harvesting human lipoaspirates. The authors would also like to thank the staff at “Koonec: Scientific and Medical Translation”. Finally, the authors express thanks to Servier Medical Art for the designed cell biology element.
Author Contributions
Conceived and designed the experiments: SP CM O. Gauthier JG CV. Performed the experiments: SP CM JL SS MM BHF O. Gauthier EL O. Geffroy CV. Analyzed the data: SP CM O. Gauthier JL SS MM JG CV. Contributed reagents/materials/analysis tools: PW. Wrote the paper: SP CM JG CV.
References
- 1. Buckwalter JA, Mankin HJ (1998) Articular cartilage repair and transplantation. Arthritis Rheum 41: 1331–1342.
- 2. Steadman JR, Rodkey WG, Rodrigo JJ (2001) Microfracture: surgical technique and rehabilitation to treat chondral defects. Clin Orthop Relat Res S362–369.
- 3. Tyyni A, Karlsson J (2000) Biological treatment of joint cartilage damage. Scand J Med Sci Sports 10: 249–265.
- 4. Hunziker EB (2002) Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis Cartilage 10: 432–463.
- 5. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, et al. (1994) Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331: 889–895.
- 6. Moseley JB Jr, Anderson AF, Browne JE, Mandelbaum BR, Micheli LJ, et al. (2010) Long-term durability of autologous chondrocyte implantation: a multicenter, observational study in US patients. Am J Sports Med 38: 238–246.
- 7. Peterson L, Vasiliadis HS, Brittberg M, Lindahl A (2010) Autologous chondrocyte implantation: a long-term follow-up. Am J Sports Med 38: 1117–1124.
- 8. Szpalski C, Barbaro M, Sagebin F, Warren SM (2012) Bone tissue engineering: current strategies and techniques–part II: Cell types. Tissue Eng Part B Rev 18: 258–269.
- 9. Chen J, Chen H, Li P, Diao H, Zhu S, et al. (2012) Simultaneous regeneration of articular cartilage and subchondral bone in vivo using MSCs induced by a spatially controlled gene delivery system in bilayered integrated scaffolds. Biomaterials 32: 4793–4805.
- 10. Vinatier C, Mrugala D, Jorgensen C, Guicheux J, Noel D (2009) Cartilage engineering: a crucial combination of cells, biomaterials and biofactors. Trends Biotechnol 27: 307–314.
- 11. Maumus M, Guerit D, Toupet K, Jorgensen C, Noel D (2011) Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology. Stem Cell Res Ther 2: 14.
- 12. Cao L, Yang F, Liu G, Yu D, Li H, et al. (2011) The promotion of cartilage defect repair using adenovirus mediated Sox9 gene transfer of rabbit bone marrow mesenchymal stem cells. Biomaterials 32: 3910–3920.
- 13. Vinardell T, Sheehy EJ, Buckley CT, Kelly DJ (2012) A comparison of the functionality and in vivo phenotypic stability of cartilaginous tissues engineered from different stem cell sources. Tissue Eng Part A 18: 1161–1170.
- 14. Guilak F, Lott KE, Awad HA, Cao Q, Hicok KC, et al. (2006) Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. J Cell Physiol 206: 229–237.
- 15. Daher SR, Johnstone BH, Phinney DG, March KL (2008) Adipose stromal/stem cells: basic and translational advances: the IFATS collection. Stem Cells 26: 2664–2665.
- 16. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143–147.
- 17. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, et al. (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279–4295.
- 18. Strioga M, Viswanathan S, Darinskas A, Slaby O, Michalek J (2012) Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev 21: 2724–2752.
- 19. Huey DJ, Hu JC, Athanasiou KA (2012) Unlike bone, cartilage regeneration remains elusive. Science 338: 917–921.
- 20. Diekman BO, Guilak F (2013) Stem cell-based therapies for osteoarthritis: challenges and opportunities. Curr Opin Rheumatol 25: 119–126.
- 21. Nelson L, Fairclough J, Archer CW (2010) Use of stem cells in the biological repair of articular cartilage. Expert Opin Biol Ther 10: 43–55.
- 22. Nooeaid P, Salih V, Beier JP, Boccaccini AR (2012) Osteochondral tissue engineering: scaffolds, stem cells and applications. J Cell Mol Med 16: 2247–2270.
- 23. Bian L, Zhai DY, Zhang EC, Mauck RL, Burdick JA (2013) Dynamic compressive loading enhances cartilage matrix synthesis and distribution and suppresses hypertrophy in hMSC-laden hyaluronic acid hydrogels. Tissue Eng Part A 18: 715–724.
- 24. Dawson E, Mapili G, Erickson K, Taqvi S, Roy K (2008) Biomaterials for stem cell differentiation. Adv Drug Deliv Rev 60: 215–228.
- 25. Marquass B, Schulz R, Hepp P, Zscharnack M, Aigner T, et al. (2011) Matrix-associated implantation of predifferentiated mesenchymal stem cells versus articular chondrocytes: in vivo results of cartilage repair after 1 year. Am J Sports Med 39: 1401–1412.
- 26. Zscharnack M, Hepp P, Richter R, Aigner T, Schulz R, et al. (2011) Repair of chronic osteochondral defects using predifferentiated mesenchymal stem cells in an ovine model. Am J Sports Med 38: 1857–1869.
- 27. Estes BT, Diekman BO, Gimble JM, Guilak F (2010) Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype. Nat Protoc 5: 1294–1311.
- 28. Weiss S, Hennig T, Bock R, Steck E, Richter W (2010) Impact of growth factors and PTHrP on early and late chondrogenic differentiation of human mesenchymal stem cells. J Cell Physiol 223: 84–93.
- 29. Sheehy EJ, Buckley CT, Kelly DJ (2011) Oxygen tension regulates the osteogenic, chondrogenic and endochondral phenotype of bone marrow derived mesenchymal stem cells. Biochem Biophys Res Commun
- 30. Silver IA (1975) Measurement of pH and ionic composition of pericellular sites. Philos Trans R Soc Lond B Biol Sci 271: 261–272.
- 31. Zhou S, Cui Z, Urban JP (2004) Factors influencing the oxygen concentration gradient from the synovial surface of articular cartilage to the cartilage-bone interface: a modeling study. Arthritis Rheum 50: 3915–3924.
- 32. Haselgrove JC, Shapiro IM, Silverton SF (1993) Computer modeling of the oxygen supply and demand of cells of the avian growth cartilage. Am J Physiol 265: C497–506.
- 33. Amarilio R, Viukov SV, Sharir A, Eshkar-Oren I, Johnson RS, et al. (2007) HIF1alpha regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis. Development 134: 3917–3928.
- 34. Markway BD, Tan GK, Brooke G, Hudson JE, Cooper-White JJ, et al. (2010) Enhanced chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells in low oxygen environment micropellet cultures. Cell Transplant 19: 29–42.
- 35. Merceron C, Vinatier C, Portron S, Masson M, Amiaud J, et al. (2010) Differential effects of hypoxia on osteochondrogenic potential of human adipose-derived stem cells. Am J Physiol Cell Physiol 298: C355–364.
- 36. Vinatier C, Magne D, Weiss P, Trojani C, Rochet N, et al. (2005) A silanized hydroxypropyl methylcellulose hydrogel for the three-dimensional culture of chondrocytes. Biomaterials 26: 6643–6651.
- 37. Merceron C, Portron S, Masson M, Lesoeur J, Fellah BH, et al. (2011) The effect of two- and three-dimensional cell culture on the chondrogenic potential of human adipose-derived mesenchymal stem cells after subcutaneous transplantation with an injectable hydrogel. Cell Transplant 20: 1575–1588.
- 38. Merceron C, Portron S, Vignes-Colombeix C, Rederstorff E, Masson M, et al. (2012) Pharmacological modulation of human mesenchymal stem cell chondrogenesis by a chemically over-sulphated polysaccharide of marine origin: potential application to cartilage regenerative medicine. Stem Cells
- 39. Vinatier C, Magne D, Moreau A, Gauthier O, Malard O, et al. (2007) Engineering cartilage with human nasal chondrocytes and a silanized hydroxypropyl methylcellulose hydrogel. J Biomed Mater Res A 80: 66–74.
- 40. Yang R, Davies CM, Archer CW, Richards RG (2003) Immunohistochemistry of matrix markers in Technovit 9100 New-embedded undecalcified bone sections. Eur Cell Mater 6: 57–71; discussion 71.
- 41. Vinatier C, Gauthier O, Fatimi A, Merceron C, Masson M, et al. (2009) An injectable cellulose-based hydrogel for the transfer of autologous nasal chondrocytes in articular cartilage defects. Biotechnol Bioeng 102: 1259–1267.
- 42. Clouet J, Vinatier C, Merceron C, Pot-vaucel M, Maugars Y, et al. (2009) From osteoarthritis treatments to future regenerative therapies for cartilage. Drug Discov Today 14: 913–925.
- 43. O'Driscoll SW, Keeley FW, Salter RB (1988) Durability of regenerated articular cartilage produced by free autogenous periosteal grafts in major full-thickness defects in joint surfaces under the influence of continuous passive motion. A follow-up report at one year. J Bone Joint Surg Am 70: 595–606.
- 44. Dickhut A, Pelttari K, Janicki P, Wagner W, Eckstein V, et al. (2009) Calcification or dedifferentiation: requirement to lock mesenchymal stem cells in a desired differentiation stage. J Cell Physiol 219: 219–226.
- 45. Owen JR, Wayne JS (2006) Influence of a superficial tangential zone over repairing cartilage defects: implications for tissue engineering. Biomech Model Mechanobiol 5: 102–110.
- 46. Shirazi R, Shirazi-Adl A, Hurtig M (2008) Role of cartilage collagen fibrils networks in knee joint biomechanics under compression. J Biomech 41: 3340–3348.
- 47. Shapiro F, Koide S, Glimcher MJ (1993) Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. J Bone Joint Surg Am 75: 532–553.
- 48. Engler AJ, Sen S, Sweeney HL, Discher DE (2006) Matrix elasticity directs stem cell lineage specification. Cell 126: 677–689.
- 49. Angele P, Yoo JU, Smith C, Mansour J, Jepsen KJ, et al. (2003) Cyclic hydrostatic pressure enhances the chondrogenic phenotype of human mesenchymal progenitor cells differentiated in vitro. J Orthop Res 21: 451–457.
- 50. Huang AH, Farrell MJ, Kim M, Mauck RL (2010) Long-term dynamic loading improves the mechanical properties of chondrogenic mesenchymal stem cell-laden hydrogel. Eur Cell Mater 19: 72–85.
- 51. Alsalameh S, Amin R, Gemba T, Lotz M (2004) Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum 50: 1522–1532.
- 52. Dowthwaite GP, Bishop JC, Redman SN, Khan IM, Rooney P, et al. (2004) The surface of articular cartilage contains a progenitor cell population. J Cell Sci 117: 889–897.
- 53. Seol D, McCabe DJ, Choe H, Zheng H, Yu Y, et al. (2012) Chondrogenic progenitor cells respond to cartilage injury. Arthritis Rheum 64: 3626–3637.
- 54. Karlsson C, Thornemo M, Henriksson HB, Lindahl A (2009) Identification of a stem cell niche in the zone of Ranvier within the knee joint. J Anat 215: 355–363.
- 55. Semenza GL, Nejfelt MK, Chi SM, Antonarakis SE (1991) Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene. Proc Natl Acad Sci U S A 88: 5680–5684.
- 56. Robins JC, Akeno N, Mukherjee A, Dalal RR, Aronow BJ, et al. (2005) Hypoxia induces chondrocyte-specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9. Bone 37: 313–322.
- 57. Aro E, Khatri R, Gerard-O'Riley R, Mangiavini L, Myllyharju J, et al. (2012) Hypoxia-inducible factor-1 (HIF-1) but not HIF-2 is essential for hypoxic induction of collagen prolyl 4-hydroxylases in primary newborn mouse epiphyseal growth plate chondrocytes. J Biol Chem 287: 37134–37144.
- 58. Pfander D, Cramer T, Schipani E, Johnson RS (2003) HIF-1alpha controls extracellular matrix synthesis by epiphyseal chondrocytes. J Cell Sci 116: 1819–1826.
- 59. Freyria AM, Mallein-Gerin F (2011) Chondrocytes or adult stem cells for cartilage repair: the indisputable role of growth factors. Injury 43: 259–265.
- 60. Gawlitta D, van Rijen MH, Schrijver EJ, Alblas J, Dhert WJ (2012) Hypoxia impedes hypertrophic chondrogenesis of human multipotent stromal cells. Tissue Eng Part A 18: 1957–1966.
- 61. Hirao M, Tamai N, Tsumaki N, Yoshikawa H, Myoui A (2006) Oxygen tension regulates chondrocyte differentiation and function during endochondral ossification. J Biol Chem 281: 31079–31092.